Advanced search×

Estimating the impact of disease in species threatened by amphibian chytrid fungus: comment on Murray et al.

Benedikt R BR Schmidt

Conserv Biol 24(3):897-9; discussion 900-2 (2010) PMID 20412085

DOI: 10.1111/j.1523-1739.2010.01507.x
Version: za2963e q8za5 q8zb5 q8zc0 q8zdc q8ze6 q8zfa q8zg8
Buy PDF

Similar articles you may find interesting…

  1. Management of sialorrhoea in motor neuron disease: A survey of current UK practice.
    Esther V Hobson, Alexander McGeachan, and Christopher J McDermott

    Amyotrophic Lateral Sclerosis and Frontotemporal De... (2013) PMID 23647474

    We used a survey of neurologists in the UK with a special interest in motor neuron disease designed to establish clinicians' attitudes towards treatment options and resources for sialorrhoea management. Twenty-three clinicians replied, representing 21 centres. Sixteen centres were specialist MND Car...
    Buy PDF
  2. Core binding factor acute myeloid leukemia: The impact of age, leukocyte count, molecular findings, and minimal residual disease.
    Montserrat Hoyos, Josep F Nomdedeu, and Jorge Sierra

    Eur J Haematol (2013) PMID 23646898

    Overall, complete remission (CR) rate was 89% (94% in 50 years, P=.002). At 5 years, cumulative incidence of relapse (CIR) was 26±1%, disease-free survival (DFS) 62±6%, and overall survival (OS) 66±4%. In multivariate analyses, leukocyte count above 20x10(9) /l, BAALC ov...
    Buy PDF
  3. Invasive fibroblasts: Fundamental difference between sporadic inclusion body myositis and polymyositis.
    Kathrin Doppler, Georgios Pantazis, and Antje Bornemann

    Muscle Nerve (2013) PMID 23649793

    Sporadic inclusion body myositis (sIBM) is a progressive disease that leads to extensive muscle weakness. The aim of this study was to determine whether the number and distribution of fibroblasts differ in sIBM when compared with polymyositis. Methods: Immunofluorescence double labelling was perform...
    Buy PDF